Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

HURATuHURA Biosciences, Inc./NV

Nasdaq · CIK 0001498382
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts402

Identity from submissions API

NameTuHURA Biosciences, Inc./NV
CIK0001498382
TickersHURA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN990360497
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone813-875-6600
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Kintara Therapeutics, Inc. (2020-08-21T04:00:00.000Z → 2024-10-22T04:00:00.000Z)
  • DelMar Pharmaceuticals, Inc. (2013-01-23T05:00:00.000Z → 2020-08-18T04:00:00.000Z)
  • Berry Only Inc. (2010-08-17T04:00:00.000Z → 2013-01-18T05:00:00.000Z)
Business address
10500 UNIVERSITY CENTER DR.
SUITE 110
TAMPA
FL
33612
FL
Mailing address
10500 UNIVERSITY CENTER DR.
SUITE 110
TAMPA
FL
33612
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

933 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 8-K 8-K 2.03,9.01 0001193125-26-467254 001-37823 261571344 34 170016 1 1
2026-11-18 4 FORM 4 0000897069-26-001944 5212
2026-11-13 10-Q 10-Q 0001193125-26-459326 001-37823 261549063 34 9726613 1 1
2026-11-13 8-K 8-K 2.02,9.01 0001193125-26-459311 001-37823 261549038 34 232561 1 1
2026-11-06 8-K 8-K 2.03,9.01 0001193125-26-452007 001-37823 261532826 34 169940 1 1
2026-10-16 8-K 8-K 2.03,9.01 0001193125-26-424228 001-37823 261466806 34 169952 1 1
2026-09-24 8-K 8-K 2.03,9.01 0001193125-26-401140 001-37823 261405301 34 169934 1 1
2026-09-17 8-K 8-K 2.03,9.01 0001193125-26-394473 001-37823 261387602 34 169967 1 1
2026-09-17 8-K/A 8-K/A 5.02,9.01 0001193125-26-393847 001-37823 261385379 34 456115 1 1
2026-09-16 8-K 8-K 5.02,9.01 0001193125-26-393206 001-37823 261384441 34 444255 1 1
2026-09-04 8-K 8-K 2.03,9.01 0001193125-26-383797 001-37823 261362709 34 171221 1 1
2026-08-28 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000897069-26-001732 005-87181 261341798 34 12472
2026-08-21 8-K 8-K 2.03,9.01 0001193125-26-361272 001-37823 261305607 34 168049 1 1
2026-08-19 8-K 8-K 3.02,5.07,9.01 0001193125-26-357087 001-37823 261296182 34 252362 1 1
2026-08-14 10-Q 10-Q 0001193125-26-350451 001-37823 261276239 34 9128336 1 1
2026-08-14 8-K 8-K 2.02,9.01 0001193125-26-350425 001-37823 261276141 34 209380 1 1
2026-08-13 8-K 8-K 2.03,9.01 0001193125-26-349540 001-37823 261274674 34 168055 1 1
2026-07-29 8-K 8-K 2.03,9.01 0001193125-26-324174 001-37823 261218702 34 169307 1 1
2026-07-09 ARS ARS 0001193125-26-299693 001-37823 261165765 34 1820244
2026-07-09 DEFA14A DEFA14A 0001193125-26-299690 001-37823 261165754 34 26403
2026-07-09 DEF 14A DEF 14A 0001193125-26-299680 001-37823 261165737 34 1855983 1 1
2026-07-07 8-K 8-K 2.03,9.01 0001193125-26-297668 001-37823 261160306 34 169368 1 1
2026-06-26 PRE 14A PRE 14A 0001193125-26-285733 001-37823 261130641 34 3484618 1 1
2026-06-17 8-K 8-K 5.08 0001193125-26-274225 001-37823 261098936 34 166542 1 1
2026-05-29 8-K 8-K 2.03,9.01 0001193125-26-248640 001-37823 261045727 34 168646 1 1
2026-05-29 4 FORM 4 0000897069-26-001285 5205
2026-05-15 10-Q 10-Q 0001193125-26-227245 001-37823 26989833 34 7797907 1 1
2026-05-15 8-K 8-K 2.02,7.01,9.01 0001193125-26-227204 001-37823 26989685 34 12487263 1 1
2026-04-30 8-K/A 8-K/A 8.01,9.01 0001193125-26-197609 001-37823 26926505 34 289031 1 1
2026-04-30 10-K/A 10-K/A 0001193125-26-197486 001-37823 26926114 34 1490963 1 1
2026-04-22 8-K 8-K 1.01,2.03,3.02,7.01,9.01 0001193125-26-168395 001-37823 26881299 34 792860 1 1
2026-04-08 424B5 424B5 0001193125-26-147748 333-291239 26848515 33 584965
2026-04-08 8-K 8-K 5.02,8.01,9.01 0001193125-26-147660 001-37823 26848297 34 288480 1 1
2026-04-01 8-K 8-K 2.02,9.01 0001193125-26-135766 001-37823 26824736 34 215070 1 1
2026-03-31 10-K 10-K 0001193125-26-134950 001-37823 26823398 34 16634010 1 1
2026-02-17 4 FORM 4 0000897069-26-000369 7069
2026-02-17 4 FORM 4 0000897069-26-000367 7128
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001107 005-87181 26641666 34 9825
2026-02-17 4 FORM 4 0000897069-26-000365 7071
2026-02-17 4 FORM 4 0000897069-26-000363 7110
2026-02-17 4 FORM 4 0000897069-26-000360 7178
2026-01-30 8-K 8-K 3.01 0001193125-26-031742 001-37823 26583234 34 167069 1 1
2026-01-08 4 FORM 4 0000897069-26-000112 5568
2026-01-08 4 FORM 4 0000897069-26-000111 5834
2025-12-17 4 xslF345X05/form4.xml 0000897069-25-001809 5322
2025-12-17 4 xslF345X05/form4.xml 0000897069-25-001807 5584
2025-12-10 8-K 8-K 1.01,8.01,9.01 0001193125-25-314302 001-37823 251562384 34 797369 1 1
2025-12-10 424B5 424B5 0001193125-25-313799 333-291239 251561338 33 663994
2025-12-05 8-K 8-K 1.01,2.03,9.01 0001193125-25-309853 001-37823 251553681 34 192926 1 1
2025-11-25 8-K 8-K 7.01 0001193125-25-294581 001-37823 251515085 34 137607 1 1
2025-11-25 424B3 424B3 0001193125-25-294575 333-291239 251515081 33 423107
2025-11-18 8-K 8-K 8.01,9.01 0001193125-25-286419 001-37823 251495696 34 456470 1 1
2025-11-14 10-Q 10-Q 0001193125-25-281539 001-37823 251481171 34 9715815 1 1
2025-11-14 8-K 8-K 2.02,9.01 0001193125-25-281522 001-37823 251481137 34 226966 1 1
2025-11-10 D xslFormDX01/primary_doc.xml 06b 0001498382-25-000004 021-563591 251466202 33 11363
2025-11-04 8-K 8-K 1.01,9.01 0001193125-25-263523 001-37823 251446367 34 174276 1 1
2025-11-03 S-3 S-3 0001193125-25-262843 333-291239 251445390 33 2029441 1 1
2025-11-03 8-K 8-K 8.01,9.01 0001193125-25-262562 001-37823 251444171 34 1559615 1 1
2025-10-31 424B3 424B3 0001193125-25-260933 333-289532 251441349 33 817947
2025-10-31 8-K 8-K 1.01,2.03,9.01 0001193125-25-260924 001-37823 251441300 34 971023 1 1
2025-10-31 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000320 005-87181 251439046 34 6799
2025-09-26 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003114 333-289532 251351950 33 2072
2025-09-26 424B3 424B3 0001193125-25-220655 333-289532 251350857 33 5855790
2025-09-25 UPLOAD filename1.pdf 0000000000-25-010492 377-08489 40733
2025-09-24 CORRESP filename1.htm 0001193125-25-215424 6230
2025-09-18 CORRESP filename1.htm 0001193125-25-207404 16170
2025-09-18 S-1/A S-1/A 0001193125-25-207395 333-289532 251323506 33 25492476 1 1
2025-09-11 8-K 8-K 1.01,9.01 0000950170-25-114235 001-37823 251308900 34 239077 1 1
2025-08-28 UPLOAD filename1.pdf 0000000000-25-009257 333-289532 43112
2025-08-25 CORRESP filename1.htm 0001193125-25-187832 22379
2025-08-20 UPLOAD filename1.pdf 0000000000-25-008859 333-289532 43775
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000897069-25-001355 005-87181 251220805 34 7455
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000897069-25-001352 005-87181 251220725 34 7480
2025-08-14 10-Q 10-Q 0000950170-25-108972 001-37823 251219961 34 8875955 1 1
2025-08-14 8-K 8-K 2.02,9.01 0000950170-25-108909 001-37823 251219584 34 225108 1 1
2025-08-12 S-1 S-1 0001193125-25-179009 333-289532 251207243 33 31692636 1 1
2025-08-12 8-K/A 8-K/A 9.01 0001193125-25-178993 001-37823 251207115 34 930553 1 1
2025-07-29 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-001060 005-87181 251160744 34 6693
2025-06-30 8-K 8-K 2.01,7.01,9.01 0000950170-25-091693 001-37823 251092928 34 229190 1 1
2025-06-27 8-K 8-K 5.03,9.01 0000950170-25-090522 001-37823 251081609 34 1855601 1 1
2025-06-24 425 425 0000950170-25-089132 162511
2025-06-24 8-K 8-K 5.07,7.01,9.01 0000950170-25-089118 001-37823 251066125 34 294842 1 1
2025-06-13 D xslFormDX01/primary_doc.xml 06b 0000950123-25-006026 021-548881 251044686 33 13751
2025-06-12 8-K 8-K 9.01 0000950170-25-085116 001-37823 251041629 34 221334 1 1
2025-06-06 425 425 0001193125-25-137145 308404
2025-06-06 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-25-137135 001-37823 251031350 34 514218 1 1
2025-06-03 425 425 0000950170-25-080612 52896
2025-05-23 ARS ARS 0001193125-25-125503 001-37823 25979353 34 1689744
2025-05-23 424B3 424B3 0001193125-25-125499 333-284787 25979344 33 15067172
2025-05-15 10-Q 10-Q 0000950170-25-072745 001-37823 25954159 34 6971631 1 1
2025-05-15 425 425 0000950170-25-072703 127832
2025-05-15 8-K 8-K 2.02,9.01 0000950170-25-072685 001-37823 25953637 34 269937 1 1
2025-05-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001589 333-284787 25948308 33 2071
2025-05-13 425 425 0000950170-25-069822 36727
2025-05-12 CORRESP filename1.htm 0001193125-25-117877 6836
2025-05-08 S-4/A S-4/A 0001193125-25-116090 333-284787 25927538 33 213537
2025-05-07 8-K/A 8-K/A 5.02 0000950170-25-065860 001-37823 25922517 34 178637 1 1
2025-05-07 425 425 0000950170-25-065063 163669
2025-05-07 8-K 8-K 1.01,5.02,9.01 0000950170-25-065057 001-37823 25919440 34 316105 1 1
2025-05-06 CORRESP filename1.htm 0001193125-25-113948 22251
2025-05-06 S-4/A S-4/A 0001193125-25-113920 333-284787 25918393 33 44597379 1 1
2025-05-05 425 425 0000950170-25-063170 51555
2025-04-28 425 425 0000950170-25-058970 52379
2025-04-08 425 425 0001193125-25-075222 33819
2025-04-01 425 425 0001193125-25-069713 001-37823 25796680 34 84977
2025-04-01 8-K 8-K 2.02,9.01 0001193125-25-069706 001-37823 25796651 34 227552 1 1
2025-03-31 10-K 10-K 0000950170-25-047921 001-37823 25795292 34 13803850 1 1
2025-03-19 4 xslF345X05/form4.xml 0000897069-25-000664 5280
2025-03-19 3 xslF345X02/form3.xml 0000897069-25-000662 11330
2025-03-18 8-K 8-K 7.01,9.01 0000950170-25-040770 001-37823 25746518 34 15154675
2025-03-12 8-K 8-K 5.02,7.01,9.01 0000950170-25-037600 001-37823 25729839 34 788427 1 1
2025-02-20 UPLOAD filename1.pdf 0000000000-25-001979 333-284787 43726
2025-02-14 8-K 8-K 1.01,9.01 0000950170-25-021395 001-37823 25630527 34 235973 1 1
2025-02-07 S-4 S-4 0001193125-25-022803 333-284787 25602889 33 42047075 1 1
2025-01-06 4 xslF345X05/form4.xml 0000897069-25-000037 5539
2025-01-06 4 xslF345X05/form4.xml 0000897069-25-000035 5432
2025-01-06 4 xslF345X05/form4.xml 0000897069-25-000033 5471
2025-01-06 4 xslF345X05/form4.xml 0000897069-25-000031 5489
2025-01-03 8-K 8-K 4.01,9.01 0000950170-25-001330 001-37823 25507478 34 182317 1 1
2024-12-23 S-8 S-8 0000950170-24-139679 333-284027 241574691 33 11073401
2024-12-12 425 425 0001193125-24-276433 001-37823 241543372 34 894783
2024-12-12 8-K 8-K 1.01,7.01,9.01 0001193125-24-276426 001-37823 241543366 34 1235818 1 1
2024-11-25 8-K 8-K 7.01,9.01 0000950170-24-130436 001-37823 241492163 34 304716
2024-11-15 8-K 8-K 5.02,9.01 0000950170-24-127673 001-37823 241468700 34 93643
2024-11-14 8-K/A 8-K/A 2.01,9.01 0000950170-24-127218 001-37823 241464377 34 1182725 1 1
2024-11-14 10-Q 10-Q 0000950170-24-127199 001-37823 241464272 34 5848795 1 1
2024-11-14 4 xslF345X05/form4.xml 0000897069-24-002166 5591
2024-11-14 4 xslF345X05/form4.xml 0000897069-24-002164 5326
2024-10-25 SC 13G theofilos13g.htm 0000897069-24-002056 005-87181 241397427 34 34889
2024-10-25 SC 13G patels13g.htm 0000897069-24-002054 005-87181 241397408 34 34934
2024-10-25 SC 13G kpbiotech13g.htm 0000897069-24-002052 005-87181 241397381 34 35293
2024-10-25 SC 13G capatel13g.htm 0000897069-24-002050 005-87181 241397349 34 35422
2024-10-25 SC 13D patelv13d.htm 0000897069-24-002048 005-87181 241397320 34 29182
2024-10-25 SC 13D bianco13d.htm 0000897069-24-002046 005-87181 241397276 34 32000
2024-10-22 4 xslF345X05/form4.xml 0000897069-24-002015 6220
2024-10-22 3 xslF345X02/form3.xml 0000897069-24-002013 15618
2024-10-22 4 xslF345X05/form4.xml 0000897069-24-002011 10113
2024-10-22 3 xslF345X02/form3.xml 0000897069-24-002009 12112
2024-10-22 4 xslF345X05/form4.xml 0000897069-24-002007 8050
2024-10-22 3 xslF345X02/form3.xml 0000897069-24-002005 11905
2024-10-22 4 xslF345X05/form4.xml 0000897069-24-002003 8011
2024-10-22 3 xslF345X02/form3.xml 0000897069-24-002001 12571
2024-10-22 3 xslF345X02/form3.xml 0000897069-24-001998 11988
2024-10-22 4 xslF345X05/form4.xml 0000897069-24-001996 12113
2024-10-22 3 xslF345X02/form3.xml 0000897069-24-001994 12147
2024-10-22 4 xslF345X05/form4.xml 0000897069-24-001992 14634
2024-10-22 3 xslF345X02/form3.xml 0000897069-24-001990 12682
2024-10-21 8-K 8-K 1.01,2.01,2.02,3.03,5.01,5.02,5.03,5.06,8.01,9.01 0000950170-24-115765 001-37823 241382000 34 6412618 1 1
2024-10-15 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-24-234378,2024-10-15 9999999995-24-003183 333-279368 241373154 33 1969
2024-10-15 8-K 8-K 7.01,8.01,9.01 0000950170-24-114690 001-37823 241372059 34 368178 1 1
2024-10-15 8-K 8-K 7.01,8.01,9.01 0000950170-24-114471 001-37823 241369430 34 365951 1 1
2024-10-08 POS AM POS AM 0001193125-24-234378 333-279368 241360382 33 154628
2024-10-08 8-K 8-K 8.01,9.01 0000950170-24-113526 001-37823 241360363 34 1236932 1 1
2024-10-08 8-K 8-K 2.02,7.01,9.01 0000950170-24-113404 001-37823 241359164 34 433168 1 1
2024-10-07 10-K 10-K 0000950170-24-113321 001-37823 241358615 34 10427571 1 1
2024-10-04 425 425 0000950170-24-112908 001-37823 241355016 34 97371
2024-10-04 8-K 8-K 5.07 0000950170-24-112899 001-37823 241354921 34 225559 1 1
2024-09-30 NT 10-K NT 10-K 0001193125-24-229119 001-37823 241340482 34 29548
2024-09-25 424B3 424B3 0001193125-24-226225 333-279368 241325541 33 271492
2024-09-25 425 425 0000950170-24-109379 001-37823 241325370 34 99232
2024-09-25 8-K 8-K 1.01,9.01 0000950170-24-109377 001-37823 241325331 34 231818 1 1
2024-09-24 425 425 0000950170-24-108896 001-37823 241317615 34 119346
2024-09-24 8-K 8-K 7.01,9.01 0000950170-24-108892 001-37823 241317604 34 253502 1 1
2024-09-20 425 425 0000950170-24-108420 001-37823 241313631 34 130236
2024-09-20 8-K 8-K 5.07,7.01,9.01 0000950170-24-108415 001-37823 241313546 34 268813 1 1
2024-09-19 425 425 0000950170-24-107917 001-37823 241308507 34 318157
2024-09-19 8-K 8-K 7.01,9.01 0000950170-24-107916 001-37823 241308503 34 446335 1 1
2024-09-18 425 425 0000950170-24-107611 001-37823 241306244 34 121520
2024-09-18 8-K 8-K 7.01,9.01 0000950170-24-107609 001-37823 241306241 34 258744 1 1
2024-09-11 425 425 0000950170-24-105345 001-37823 241291482 34 326986
2024-09-11 8-K 8-K 7.01,8.01,9.01 0000950170-24-105344 001-37823 241291479 34 476078 1 1
2024-09-09 425 425 0000950170-24-104743 001-37823 241287335 34 449482
2024-09-09 8-K 8-K 7.01,9.01 0000950170-24-104739 001-37823 241287262 34 601657 1 1
2024-09-03 425 425 0000950170-24-102944 001-37823 241275153 34 106514
2024-09-03 8-K 8-K 7.01,9.01 0000950170-24-102932 001-37823 241275095 34 239059 1 1
2024-08-19 425 425 0000950170-24-098290 001-37823 241218413 34 235606
2024-08-19 8-K 8-K 7.01,8.01,9.01 0000950170-24-098289 001-37823 241218402 34 369915 1 1
2024-08-19 424B3 424B3 0001193125-24-202235 333-279368 241217893 33 9036894
2024-08-13 SEC STAFF LETTER filename1.pdf 9999999997-24-003551 64488
2024-08-13 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2024-08-13 16:15:00 9999999995-24-002516 333-279368 241203889 33 1956
2024-08-12 CORRESP filename1.htm 0001193125-24-198971 5668
2024-08-12 S-4/A S-4/A 0001193125-24-198962 333-279368 241197760 33 165467
2024-08-08 CORRESP filename1.htm 0001193125-24-197114 18756
2024-08-08 S-4/A S-4/A 0001193125-24-197111 333-279368 241189767 33 8512509
2024-08-01 UPLOAD filename1.pdf 0000000000-24-008778 333-279368 46770
2024-07-19 CORRESP filename1.htm 0001193125-24-181722 22597
2024-07-19 S-4/A S-4/A 0001193125-24-181706 333-279368 241128393 33 23282904 1 1
2024-07-12 8-K 8-K 5.03,9.01 0000950170-24-083280 001-37823 241115271 34 1620092 1 1
2024-07-10 UPLOAD filename1.pdf 0000000000-24-007825 333-279368 49581
2024-07-08 425 425 0000950170-24-081938 001-37823 241103327 34 263190
2024-07-08 8-K 8-K 7.01,8.01,9.01 0000950170-24-081937 001-37823 241103322 34 408313 1 1
2024-07-01 425 425 0000950170-24-079281 001-37823 241088316 34 456558
2024-07-01 8-K 8-K 7.01,8.01,9.01 0000950170-24-079280 001-37823 241088299 34 596968 1 1
2024-06-27 CORRESP filename1.htm 0001193125-24-170647 85416
2024-06-27 S-4/A S-4/A 0001193125-24-170640 333-279368 241079751 33 22723145 1 1
2024-06-24 8-K 8-K 5.07 0000950170-24-076467 001-37823 241062174 34 228088 1 1
2024-06-13 425 425 0000950170-24-073002 001-37823 241041314 34 65678
2024-06-13 8-K 8-K 3.01 0000950170-24-072991 001-37823 241041202 34 195673 1 1
2024-06-10 SEC STAFF LETTER filename1.pdf 9999999997-24-002922 65405
2024-06-07 UPLOAD filename1.pdf 0000000000-24-006585 333-279368 81940
2024-06-03 425 425 0000950170-24-067672 001-37823 241012129 34 246964
2024-06-03 8-K 8-K 7.01,9.01 0000950170-24-067670 001-37823 241012120 34 389455 1 1
2024-05-17 ARS ARS 0000950170-24-061641 001-37823 24959747 34 1498087
2024-05-17 DEF 14A DEF 14A 0000950170-24-061626 001-37823 24959567 34 3257250 1 1
2024-05-14 425 425 0000950170-24-059734 001-37823 24945399 34 338985
2024-05-14 8-K 8-K 2.02,7.01 0000950170-24-059716 001-37823 24945335 34 482292 1 1
2024-05-14 10-Q 10-Q 0000950170-24-059694 001-37823 24945165 34 7336889 1 1
2024-05-13 S-4 S-4 0001193125-24-137213 333-279368 24939042 33 11133814
2024-05-09 8-K 8-K 5.08 0000950170-24-057263 001-37823 24931904 34 176259 1 1
2024-04-25 8-K 8-K 7.01 0000950170-24-047950 001-37823 24873259 34 538641 1 1
2024-04-25 425 425 0000950170-24-047951 001-37823 24873258 34 399519
2024-04-03 425 425 0000950170-24-040656 001-37823 24816835 34 19179880
2024-04-03 8-K 8-K 1.01,5.02,7.01,8.01,9.01 0000950170-24-040655 001-37823 24816831 34 19565974 1 1
2024-03-13 RW RW 0001193125-24-066370 333-274864 24744537 NE 7648
2024-02-27 8-K 8-K 8.01 0000950170-24-020612 001-37823 24681904 34 166095 1 1
2024-02-26 8-K 8-K 8.01 0000950170-24-019730 001-37823 24673510 34 161768 1 1
2024-02-22 8-K 8-K 8.01 0000950170-24-018403 001-37823 24662237 34 157756 1 1
2024-02-14 8-K 8-K 2.02,7.01,9.01 0000950170-24-015213 001-37823 24638131 34 439490 1 1
2024-02-14 10-Q 10-Q 0000950170-24-015204 001-37823 24637811 34 7140201 1 1
2024-02-12 8-K 8-K 7.01,8.01,9.01 0000950170-24-013584 001-37823 24617595 34 353248 1 1
2023-12-18 8-K 8-K 8.01,9.01 0000950170-23-071082 001-37823 231493813 34 212289 1 1
2023-12-18 424B5 424B5 0000950170-23-071075 333-254662 231493707 33 21632
2023-12-15 8-K 8-K 3.01 0000950170-23-070743 001-37823 231490483 34 185423 1 1
2023-12-07 8-K 8-K 8.01,9.01 0000950170-23-068688 001-37823 231471195 34 339884 1 1
2023-12-05 8-K 8-K 3.01,9.01 0000950170-23-067953 001-37823 231465338 34 351536 1 1
2023-11-21 8-K 8-K 5.02 0000950170-23-065303 001-37823 231424531 34 184606 1 1
2023-11-13 8-K 8-K 2.02,7.01,9.01 0000950170-23-062968 001-37823 231398924 34 437107 1 1
2023-11-13 10-Q 10-Q 0000950170-23-062915 001-37823 231398598 34 7252342 1 1
2023-10-31 8-K 8-K 7.01,8.01 0000950170-23-056547 001-37823 231362342 34 364936 1 1
2023-10-27 S-1/A S-1/A 0000950170-23-055977 333-274864 231355541 33 1295345 1 1
2023-10-24 S-1/A S-1/A 0000950170-23-054903 333-274864 231343114 33 2558776 1 1
2023-10-10 8-K 8-K 5.07 0000950170-23-052626 001-37823 231318004 34 202040 1 1
2023-10-04 S-1 S-1 0000950170-23-051922 333-274864 231308474 33 1229202 1 1
2023-09-26 8-K 8-K 3.01 0000950170-23-049926 001-37823 231280565 34 197080 1 1
2023-09-19 8-K 8-K 1.01,9.01 0000950170-23-048785 001-37823 231264059 34 743544 1 1
2023-09-19 424B5 424B5 0000950170-23-048783 333-254662 231263992 33 619258
2023-09-18 8-K 8-K 2.02,7.01,9.01 0000950170-23-048593 001-37823 231261551 34 443631 1 1
2023-09-18 10-K 10-K 0000950170-23-048588 001-37823 231261474 34 13003486 1 1
2023-09-11 DEF 14A DEF 14A 0000950170-23-047463 001-37823 231247789 34 3861573 1 1
2023-09-01 4 xslF345X05/ownership.xml 0001493152-23-031538 5678
2023-09-01 4 xslF345X05/ownership.xml 0001493152-23-031535 5654
2023-09-01 4 xslF345X05/ownership.xml 0001493152-23-031537 5754
2023-09-01 4 xslF345X05/ownership.xml 0001493152-23-031536 5539
2023-09-01 4 xslF345X05/ownership.xml 0001493152-23-031534 5608
2023-09-01 PRE 14A PRE 14A 0000950170-23-046052 001-37823 231232501 34 3951052 1 1
2023-06-30 8-K 8-K 5.03,5.07,9.01 0000950170-23-031164 001-37823 231062655 34 336520 1 1
2023-06-15 8-K 8-K 5.07 0000950170-23-028256 001-37823 231017159 34 203954 1 1
2023-06-02 4 xslF345X04/ownership.xml 0001493152-23-019950 5073
2023-06-02 8-K 8-K 5.02,8.01 0000950170-23-025898 001-37823 23986823 34 203254 1 1
2023-05-25 8-K 8-K 5.07 0000950170-23-024285 001-37823 23961810 34 201583 1 1
2023-05-11 8-K 8-K 2.02,7.01,9.01 0000950170-23-020871 001-37823 23909010 34 506633 1 1
2023-05-11 10-Q 10-Q 0000950170-23-020854 001-37823 23908928 34 8802599 1 1
2023-05-09 8-K 8-K 5.07 0000950170-23-019830 001-37823 23903135 34 203093 1 1
2023-03-31 DEFA14A DEFA14A 0000950170-23-011442 001-37823 23789324 34 247495
2023-03-31 DEF 14A DEF 14A 0000950170-23-011383 001-37823 23787783 34 1736632
2023-03-31 ARS ARS 0000950170-23-011379 001-37823 23787742 34 2686767
2023-03-21 PRE 14A PRE 14A 0000950170-23-008975 001-37823 23750530 34 1123989
2023-03-10 8-K 8-K 7.01 0000950170-23-007371 001-37823 23724982 34 182855 1 1
2023-02-14 8-K 8-K 2.02,7.01,9.01 0000950170-23-002808 001-37823 23631363 34 497555 1 1
2023-02-14 10-Q 10-Q 0000950170-23-002805 001-37823 23631239 34 8521435 1 1
2023-02-13 SC 13G/A AMENDMENT NO. 1 0000929638-23-000412 005-87181 23618951 34 78071
2023-01-06 4 xslF345X03/ownership.xml 0001493152-23-000860 5952
2022-12-05 8-K form8-k.htm 2.02,7.01,8.01,9.01 0001493152-22-034417 001-37823 221443788 34 7783809 1 1
2022-11-30 8-K 8-K 8.01,9.01 0000950170-22-025838 001-37823 221434361 34 378602 1 1
2022-11-14 8-K 8-K 3.03,5.03,9.01 0000950170-22-024708 001-37823 221380426 34 246335 1 1
2022-11-09 8-K 8-K 2.02,7.01,9.01 0000950170-22-024000 001-37823 221374051 34 466493 1 1
2022-11-09 10-Q 10-Q 0000950170-22-023988 001-37823 221373706 34 9276102 1 1
2022-10-19 8-K 8-K 7.01,8.01,9.01 0000950170-22-019697 001-37823 221317274 34 383859 1 1
2022-09-27 S-8 S-8 0000950170-22-018902 333-267631 221271564 33 278496
2022-09-27 8-K 8-K 2.02,7.01,9.01 0000950170-22-018866 001-37823 221267426 34 484001 1 1
2022-09-27 10-K 10-K 0000950170-22-018865 001-37823 221267330 34 16347389 1 1
2022-08-03 4 xslF345X03/ownership.xml 0001493152-22-021172 7344
2022-08-03 4 xslF345X03/ownership.xml 0001493152-22-021171 8207
2022-08-03 4 xslF345X03/ownership.xml 0001493152-22-021170 7415
2022-08-03 8-K 8-K 1.01,8.01,9.01 0000950170-22-014228 001-37823 221132560 34 1109913 1 1
2022-08-03 424B5 424B5 0000950170-22-014028 333-254662 221131104 33 885049
2022-07-05 4 xslF345X03/ownership.xml 0001493152-22-018526 5692
2022-07-05 4 xslF345X03/ownership.xml 0001493152-22-018527 5552
2022-07-05 4 xslF345X03/ownership.xml 0001493152-22-018529 5574
2022-06-22 8-K 8-K 5.03,5.07,9.01 0000950170-22-011967 001-37823 221032239 34 325715 1 1
2022-06-16 8-K 8-K 7.01,8.01,9.01 0000950170-22-011724 001-37823 221019413 34 387710 1 1
2022-06-03 8-K 8-K 3.01,8.01,9.01 0000950170-22-011116 001-37823 22993057 34 393242 1 1
2022-05-24 8-K 8-K 5.02,9.01 0000950170-22-010535 001-37823 22954078 34 270429 1 1
2022-05-13 10-Q 10-Q 0000950170-22-009809 001-37823 22920359 34 10271096 1 1
2022-05-13 8-K 8-K 2.02,7.01,9.01 0000950170-22-009805 001-37823 22920331 34 522239 1 1
2022-05-06 DEFA14A DEFA14A 0001564590-22-018580 001-37823 22901139 34 1790013
2022-05-06 DEF 14A DEF 14A 0001564590-22-018573 001-37823 22901011 34 2478415
2022-04-26 PRE 14A PRE 14A 0001564590-22-015691 001-37823 22854539 34 2479404
2022-04-20 SC 13G sched13g.htm 0000929638-22-000809 005-87181 22838920 34 78152
2022-04-18 8-K 8-K 5.03 0000950170-22-005759 001-37823 22832531 34 200052 1 1
2022-04-13 424B5 424B5 0000950170-22-005659 333-254662 22824887 33 872009
2022-04-13 8-K 8-K 1.01 0000950170-22-005658 001-37823 22824852 34 1237157 1 1
2022-02-17 4 xslF345X03/kintara_fm4feb152022.xml 0000905718-22-000393 5372
2022-02-11 8-K KTRA-8-K Q2 FS 20211231 2.02,7.01,9.01 0001564590-22-004693 001-37823 22616903 34 475976 1 1
2022-02-11 10-Q 10-Q 0001564590-22-004688 001-37823 22616808 34 9431721 1 1
2022-02-08 8-K 8-K 5.02 0001564590-22-004233 001-37823 22601602 34 163502 1 1
2022-02-07 SC 13G/A SCHEDULE 13G/A 0001437749-22-002588 005-87181 22596641 34 104070
2022-01-18 8-K 8-K 8.01 0001564590-22-001469 001-37823 22535484 34 185745 1 1
2022-01-10 8-K 8-K 8.01,9.01 0001564590-22-000762 001-37823 22519668 34 7115759 1 1
2021-12-09 4 FORM 4 SUBMISSION 0000899243-21-047520 4765
2021-12-08 4 FORM 4 SUBMISSION 0000899243-21-047320 12048
2021-12-06 8-K 8-K 3.01 0001564590-21-059374 001-37823 211472031 34 188642 1 1
2021-11-24 4 FORM 4 SUBMISSION 0000899243-21-046043 4795
2021-11-15 8-K 8-K 2.02,7.01,9.01 0001564590-21-056817 001-37823 211406575 34 443998 1 1
2021-11-15 10-Q 10-Q Q1 FY 2022 0001564590-21-056793 001-37823 211406140 34 8885742 1 1
2021-11-12 8-K 8-K 5.02,9.01 0001564590-21-056375 001-37823 211398851 34 548328 1 1
2021-11-10 4 FORM 4 SUBMISSION 0000899243-21-043913 9409
2021-10-29 8-K 8-K 5.02 0001564590-21-052943 001-37823 211363282 34 194520 1 1
2021-09-29 8-K 8-K 2.02,7.01,9.01 0001564590-21-049316 001-37823 211289449 34 449092 1 1
2021-09-28 S-8 S-8 0001564590-21-049262 333-259858 211287539 33 169099
2021-09-28 10-K 10-K 0001564590-21-049235 001-37823 211286903 34 14250714 1 1
2021-09-28 8-K 8-K 1.01,8.01,9.01 0001564590-21-049108 001-37823 211283421 34 1242992 1 1
2021-09-27 424B5 424B5 0001564590-21-049072 333-254662 211282843 33 630050
2021-09-22 4 xslF345X03/kintara_fm4sep222021.xml 0000905718-21-001227 5536
2021-09-22 4 xslF345X03/kintara_fm4sep222021.xml 0000905718-21-001225 5549
2021-09-22 4 xslF345X03/kintara_fm4sep222021.xml 0000905718-21-001223 5567
2021-09-22 4 xslF345X03/kintara_fm4sep222021.xml 0000905718-21-001221 5570
2021-09-22 4 xslF345X03/kintara_fm4sep222021.xml 0000905718-21-001219 5689
2021-09-07 8-K 8-K 8.01,9.01 0001564590-21-047225 001-37823 211240134 34 7200328 1 1
2021-06-28 8-K 8-K 5.03,5.07,9.01 0001564590-21-034654 001-37823 211049532 34 702476 1 1
2021-05-14 8-K 8-K 2.02,7.01,9.01 0001564590-21-027816 001-37823 21922017 34 449865 1 1
2021-05-13 10-Q 10-Q 0001564590-21-027558 001-37823 21919845 34 10856684 1 1
2021-05-07 DEF 14A DEF 14A 0001564590-21-025548 001-37823 21902587 34 1077270
2021-05-03 4 xslF345X03/kintara_fm4apr292021.xml 0000905718-21-000652 5636
2021-05-03 3 xslF345X02/kintara_fm3apr292021.xml 0000905718-21-000650 8726
2021-05-03 8-K 8-K 5.02 0001564590-21-022824 001-37823 21883517 34 36161
2021-04-29 4 xslF345X03/kintara_fm4apr292021.xml 0000905718-21-000631 9899
2021-04-29 4 xslF345X03/kintara_fm4apr292021.xml 0000905718-21-000630 9043
2021-04-29 4 xslF345X03/kintara_fm4apr292021.xml 0000905718-21-000629 8975
2021-04-27 PRE 14A PRE 14A 0001564590-21-020973 001-37823 21860214 34 2546671
2021-04-01 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-04-01 16:15:00 9999999995-21-001258 333-254662 21800455 33 1896
2021-03-31 4 xslF345X03/kintara_fm4mar312021.xml 0000905718-21-000505 4815
2021-03-31 4 xslF345X03/kintara_fm4mar312021.xml 0000905718-21-000503 5739
2021-03-31 4 xslF345X03/kintara_fm4mar312021.xml 0000905718-21-000501 4883
2021-03-30 CORRESP filename1.htm 0001193125-21-100320 6662
2021-03-30 UPLOAD filename1.pdf 0000000000-21-003802 40380
2021-03-24 S-3 S-3 0001564590-21-015137 333-254662 21768912 33 1885474
2021-02-12 8-K 8-K 2.02,7.01,9.01 0001193125-21-040150 001-37823 21623071 34 66049
2021-02-12 10-Q 10-Q 0001564590-21-005642 001-37823 21622490 34 8843948 1
2021-02-08 SC 13G/A SCHEDULE 13G/A 0001437749-21-002216 005-87181 21601066 34 149722
2021-01-29 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-21-005155 005-87181 21568060 34 93550
2021-01-04 4 FORM 4 SUBMISSION 0000899243-21-000044 5791
2021-01-04 4 FORM 4 SUBMISSION 0000899243-21-000043 4825
2021-01-04 4 FORM 4 SUBMISSION 0000899243-21-000042 4935
2020-11-16 SC 13G SCHEDULE 13G 0001437749-20-023976 005-87181 201315718 34 154803
2020-11-13 8-K 8-K 2.02,7.01,9.01 0001564590-20-053734 001-37823 201309228 34 268212
2020-11-12 10-Q 10-Q 0001564590-20-053563 001-37823 201306779 34 7262855 1
2020-11-04 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-11-04 16:15:00 9999999995-20-003083 333-249675 201288451 33 1897
2020-11-04 424B4 424B4 0001564590-20-050543 333-249675 201287299 33 1425856
2020-11-02 CORRESP filename1.htm 0001564590-20-049516 15715
2020-10-30 UPLOAD filename1.pdf 0000000000-20-010308 40437
2020-10-26 S-3 S-3 0001564590-20-047646 333-249675 201261255 33 1595924
2020-09-30 4 xslF345X03/kintara_fm4sep302020.xml 0000905718-20-000999 4816
2020-09-30 4 xslF345X03/kintara_fm4sep302020.xml 0000905718-20-000998 4884
2020-09-30 4 xslF345X03/kintara_fm4sep302020.xml 0000905718-20-000997 5740
2020-09-24 4 xslF345X03/kintara_fm4sep222020.xml 0000905718-20-000984 5635
2020-09-24 4/A xslF345X03/kintara_fm4anov142019.xml 0000905718-20-000982 5783
2020-09-21 8-K 8-K 2.02,7.01,9.01 0001564590-20-044055 001-37823 201185279 34 261921
2020-09-21 S-8 S-8 0001564590-20-044027 333-248928 201184864 33 195002
2020-09-18 10-K 10-K 0001564590-20-044019 001-37823 201184797 34 10257448 1
2020-09-17 4 xslF345X03/kintara_fm4sep152020.xml 0000905718-20-000975 5703
2020-09-17 4 xslF345X03/kintara_fm4sep152020.xml 0000905718-20-000973 5647
2020-09-17 4 xslF345X03/kintara_fm4sep152020.xml 0000905718-20-000971 5635
2020-09-17 4 xslF345X03/kintara_fm4sep152020.xml 0000905718-20-000969 5640
2020-09-17 4 xslF345X03/kintara_fm4sep152020.xml 0000905718-20-000967 5569
2020-09-17 4 xslF345X03/kintara_fm4sep152020.xml 0000905718-20-000965 5549
2020-09-17 4 xslF345X03/kintara_fm4sep152020.xml 0000905718-20-000963 5536
2020-09-17 4 xslF345X03/kintara_fm4sep152020.xml 0000905718-20-000961 5689
2020-09-01 8-K CURRENT REPORT 1.01,3.02,5.03,7.01,9.01 0001213900-20-024674 001-37823 201153368 34 309547
2020-08-28 SC 13G sc13g.htm 0001493152-20-016923 005-87181 201147897 34 157843
2020-08-28 D xslFormDX01/primary_doc.xml 06b 0000905718-20-000907 021-374369 201145801 33 13465
2020-08-27 D xslFormDX01/primary_doc.xml 06b 0000905718-20-000905 021-374299 201142435 33 13465
2020-08-25 8-K CURRENT REPORT 1.01,3.02,5.03,7.01,9.01 0001213900-20-023568 001-37823 201129635 34 195070
2020-08-24 8-K/A AMENDMENT TO FORM 8-K 9.01 0001213900-20-023471 001-37823 201127984 34 539810
2020-08-21 8-K CURRENT REPORT 1.01,2.01,3.01,3.02,3.03,5.02,5.03,9.01 0001213900-20-023287 001-37823 201123952 34 1498895
2020-08-21 4 xslF345X03/ownership.xml 0001213900-20-023272 5318
2020-08-21 4 xslF345X03/ownership.xml 0001213900-20-023271 5297
2020-08-21 3 xslF345X02/ownership.xml 0001213900-20-023264 9140
2020-08-21 3 xslF345X02/ownership.xml 0001213900-20-023261 10556
2020-08-18 425 FORM 425 0001213900-20-022614 16903
2020-08-17 8-K CURRENT REPORT 5.07,8.01,9.01 0001213900-20-022409 001-37823 201108072 34 45997
2020-08-17 425 CURRENT REPORT 0001213900-20-022410 46385
2020-07-28 425 FORM 425 0001213900-20-018865 11042
2020-07-02 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2020-07-02 16:15:00 9999999995-20-001631 333-239215 201011997 33 1796
2020-07-02 424B3 424B3 0001193125-20-186917 333-239215 201010214 33 5750013
2020-07-02 3 xslF345X02/ownership.xml 0001213900-20-016559 9030
2020-07-02 S-4/A FORM S-4/A 0001193125-20-185478 333-239215 201006694 33 12168885 1
2020-06-30 CORRESP filename1.htm 0001193125-20-184125 6198
2020-06-30 4 xslF345X03/ownership.xml 0001213900-20-016319 7611
2020-06-30 4 xslF345X03/ownership.xml 0001213900-20-016317 7635
2020-06-30 4 xslF345X03/ownership.xml 0001213900-20-016315 8479
2020-06-30 4 xslF345X03/ownership.xml 0001213900-20-016310 7483
2020-06-30 4 xslF345X03/ownership.xml 0001213900-20-016308 5810
2020-06-30 4 xslF345X03/ownership.xml 0001213900-20-016306 5785
2020-06-30 4 xslF345X03/ownership.xml 0001213900-20-016303 5849
2020-06-30 4 xslF345X03/ownership.xml 0001213900-20-016299 11167
2020-06-26 8-K FORM 8-K 5.07 0001193125-20-181055 001-37823 20994641 34 27490
2020-06-24 8-K FORM 8-K 8.01,9.01 0001193125-20-177765 001-37823 20986377 34 16156117
2020-06-24 425 FORM 8-K 0001193125-20-177766 001-37823 20986364 34 16156671
2020-06-23 UPLOAD filename1.pdf 0000000000-20-005608 40334

Latest XBRL company facts

One latest value per concept from companyfacts (402 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 65.76M 2026-11-10 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
dei EntityPublicFloat Entity Public Float USD 111.00M 2025-06-30 2025 FY 10-K/A 2026-04-30 0001193125-26-197486
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 691,036 2025-01-01 2025-12-31 DEF 14A 2026-07-09 0001193125-26-299680
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.83M 2025-01-01 2025-12-31 DEF 14A 2026-07-09 0001193125-26-299680
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 0.32 2025-01-01 2025-12-31 DEF 14A 2026-07-09 0001193125-26-299680
invest InvestmentOptionsExercisePrice Investment Options, Exercise Price USD 1 2014-07-01 2014-09-30 2015 Q1 10-Q 2014-11-07 0001013762-14-001293
invest InvestmentWarrantsExercisePrice Investment Warrants, Exercise Price USD 1.25 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-27 0001213900-17-010055
us-gaap AccountsPayable Accounts Payable (Deprecated 2009-01-31) USD 4,120 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 7.20M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 5.92M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap AccountsPayableRelatedPartiesCurrentAndNoncurrent Accounts Payable, Related Parties USD 118,761 2013-12-31 2013 FY 10-K 2014-03-10 0001013762-14-000210
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 244,906 2014-06-30 2014 FY 10-K 2014-08-28 0001013762-14-001054
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 0 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.13M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap AccumulatedAmortizationDeferredFinanceCosts Accumulated Amortization, Debt Issuance Costs USD 674,948 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2.24M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap AccumulatedOtherComprehensiveIncomeLossBeforeTax Accumulated Other Comprehensive Income (Loss), before Tax (Deprecated 2009-01-31) USD -87 2011-12-31 2012 Q2 10-Q 2012-02-07 0001165527-12-000084
us-gaap AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, before Tax (Deprecated 2009-01-31) USD 87 2012-06-30 2012 FY 10-K/A 2012-12-20 0001165527-12-001331
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 21,000 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.72M 2015-06-30 2015 FY 10-K 2015-11-16 0001013762-15-001103
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 182.97M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap AdjustmentForAmortization Amortization USD 0 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 35,000 2021-07-01 2022-06-30 2023 FY 10-K 2023-09-18 0000950170-23-048588
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 6.52M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions APIC, Share-based Payment Arrangement, Recognition and Exercise USD 20,846 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-15 0001013762-13-000733
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 98,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 53,006 2016-07-01 2017-06-30 8-K 2019-06-03 0001213900-19-009915
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 6.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax USD 100,868 2015-07-01 2016-06-30 2017 FY 10-K 2017-09-27 0001213900-17-010055
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 481,424 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 674,948 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 3.23M 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-18 0000950170-23-048588
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 49.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap AssetAcquisitionContingentConsiderationLiabilityCurrent AssetAcquisitionContingentConsiderationLiabilityCurrent USD 2.78M 2025-09-30 2025 Q3 10-Q 2025-11-14 0001193125-25-281539
us-gaap Assets Assets USD 36.24M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap AssetsCurrent Assets, Current USD 3.68M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 4.13M 2024-10-18 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares shares 8.73M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-08 0001013762-13-001377
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 3.67M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 16.72M 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 240,000 2022-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 70,097 2024-10-18 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other USD 11,000 2022-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 370,030 2024-10-18 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable USD 1.79M 2024-10-18 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other USD 188,000 2022-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment USD 175,000 2022-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap Cash Cash USD 3,979 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 969,000 2020-07-01 2021-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 1.89M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 1.25M 2019-07-01 2020-03-31 2020 Q3 10-Q 2020-05-13 0001213900-20-011910
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 1.89M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -1.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 9.00M 2017-06-30 2017 FY 10-K 2017-09-27 0001213900-17-010055
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 527,000 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 3,979 2009-06-24 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 4.38M 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) CAD/Warrant 0.5 2014-03-31 2014 Q1 10-Q 2014-05-15 0001013762-14-000563
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 2.99 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 1.21M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 8,000 2014-03-31 2014 Q1 10-Q 2014-05-15 0001013762-14-000563
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 32.26M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 1.13M 2025-06-30 2025 Q3 10-Q 2025-11-14 0001193125-25-281539
us-gaap CommonStockholdersEquity Common Stockholders' Equity (Deprecated 2013-01-31) USD -2.02M 2013-03-31 2013 Q1 10-Q 2013-05-15 0001013762-13-000733
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 65.76M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 65.76M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 0 2012-03-31 2012 Q3 10-Q/A 2012-06-05 0001165527-12-000600
us-gaap CommonStockShareSubscriptionsButUnissuedValue Common Stock, Share Subscriptions but Unissued, Value (Deprecated 2009-01-31) USD 0 2009-06-24 2011-12-31 2012 Q2 10-Q 2012-02-07 0001165527-12-000084
us-gaap CommonStockValue Common Stock, Value, Issued USD 65,758 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 5.48M 2016-07-01 2017-03-31 2017 Q3 10-Q 2017-05-12 0001213900-17-005082
us-gaap ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure USD 65,000 2023-07-01 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 1.58M 2017-06-30 2017 FY 10-K 2017-09-27 0001213900-17-010055
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 37,188 2016-07-01 2017-03-31 2017 Q3 10-Q 2017-05-12 0001213900-17-005082
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 2.32M 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 0 2020-09-30 2021 Q1 10-Q 2020-11-12 0001564590-20-053563
us-gaap CostsAndExpenses Costs and Expenses USD 53,492 2009-06-24 2011-12-31 2012 Q2 10-Q 2012-02-07 0001165527-12-000084
us-gaap CreditDerivativePurchasedCreditProtection Credit Derivative, Purchased Credit Protection USD 62,943 2014-07-01 2015-06-30 2015 FY 10-K 2015-11-16 0001013762-15-001103
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 1,600 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 1,600 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DebtInstrumentIssuedPrincipal DebtInstrumentIssuedPrincipal USD 3.01M 2025-02-12 2025 Q1 10-Q 2025-05-15 0000950170-25-072745
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD 2.71M 2013-01-01 2013-12-31 2014 FY 10-K 2014-08-28 0001013762-14-001054
us-gaap DeferredCompensationShareBasedArrangementsLiabilityCurrent Deferred Compensation Share-based Arrangements, Liability, Current USD 183,499 2013-03-31 2013 Q1 10-Q 2013-05-15 0001013762-13-000733
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 85,000 2020-06-30 2021 FY 10-K 2021-09-28 0001564590-21-049235
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 94,000 2020-06-30 2021 FY 10-K 2021-09-28 0001564590-21-049235
us-gaap DeferredCostsCurrentAndNoncurrent Deferred Costs USD 178,645 2020-06-30 2020 FY 10-K 2020-09-18 0001564590-20-044019
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 6.92M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 6.92M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 2.86M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 197,919 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 11.00M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 68,217 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 123.03M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 806,000 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 2.66M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 94.38M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 57,600 2012-06-30 2012 FY 10-K/A 2012-12-20 0001165527-12-001331
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 33.60M 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 72 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 8,640 2012-06-30 2012 FY 10-K/A 2012-12-20 0001165527-12-001331
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 685,000 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses USD 375,000 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.72M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 373,904 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 120.37M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 197,919 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 2.76M 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 0 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap Depreciation Depreciation USD 79,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 78,669 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap DerivativeAssetsLiabilitiesAtFairValueNet Derivative Assets (Liabilities), at Fair Value, Net USD 0 2020-03-31 2020 Q3 10-Q 2020-05-13 0001213900-20-011910
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 432,386 2018-07-01 2019-06-30 2020 Q1 10-Q 2019-11-13 0001213900-19-023215
us-gaap DerivativeLiabilities Derivative Liability USD 0 2020-06-30 2020 FY 10-K 2020-09-18 0001564590-20-044019
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 137,000 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 1,117 2018-06-30 2020 FY 10-K 2020-09-18 0001564590-20-044019
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 21.06M 2014-12-31 2015 Q2 10-Q 2015-02-12 0001013762-15-000152
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 6,267 2015-06-30 2015 FY 10-K 2015-11-16 0001013762-15-001103
us-gaap DividendsPreferredStockCash Dividends, Preferred Stock, Cash USD 6,267 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap DividendsPreferredStockStock Dividends, Preferred Stock, Stock USD 2,089 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap DueToOfficersOrStockholders Due to Officers or Stockholders (Deprecated 2009-01-31) USD 15,454 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 298,000 2023-06-30 2023 FY 10-K 2023-09-18 0000950170-23-048588
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.37 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0.54 2016-07-01 2017-03-31 2017 Q3 10-Q 2017-05-12 0001213900-17-005082
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.37 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 2.459 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.189 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.61 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 751,167 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.025 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -87 2009-06-24 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 93,016 2016-03-31 2016 Q3 10-Q 2016-05-12 0001013762-16-001577
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 925,270 2018-07-01 2019-06-30 2020 FY 10-K 2020-09-18 0001564590-20-044019
us-gaap FairValueConcentrationOfRiskDerivativeFinancialInstrumentsLiabilities Fair Value, Concentration of Risk, Derivative Instruments, Liabilities USD 3,389 2018-03-31 2018 Q3 10-Q 2018-05-15 0001213900-18-006318
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value USD 9,278 2012-06-30 2012 FY 10-K/A 2012-12-20 0001165527-12-001331
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 51,971 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 25,985 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 25,985 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 12,993 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 33,153 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.075 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 2,000 2020-06-30 2021 Q3 10-Q 2021-05-13 0001564590-21-027558
us-gaap FiniteLivedIntangibleAssetsPeriodIncreaseDecrease Finite-Lived Intangible Assets, Period Increase (Decrease) USD -12,649 2017-07-01 2018-06-30 2019 FY 10-K 2019-09-09 0001213900-19-017497
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -1,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD -433,503 2018-07-01 2019-06-30 2020 FY 10-K 2020-09-18 0001564590-20-044019
us-gaap GainLossOnSaleOfDerivatives Gain (Loss) on Sale of Derivatives USD -2.20M 2013-01-01 2013-12-31 2014 FY 10-K 2014-08-28 0001013762-14-001054
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 6.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap Goodwill Goodwill USD 10.74M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap GrantsReceivable Grants Receivable USD 222,702 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 9,820 2015-06-30 2015 FY 10-K 2015-11-16 0001013762-15-001103
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -65,095 2009-06-24 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -30.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -30.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares 0 2011-07-01 2011-12-31 2012 Q2 10-Q 2012-02-07 0001165527-12-000084
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2009-06-24 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 1,600 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -74.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD -17,000 2023-07-01 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -110,000 2023-07-01 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -6.32M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 28,441 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 18.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 33,172 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 1,600 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 380,513 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 4,120 2009-06-24 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 1.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2009-06-24 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD -339,583 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 276 2014-07-01 2015-03-31 2015 Q3 10-Q 2015-05-15 0001013762-15-000525
us-gaap IncreaseDecreaseInDueToOfficersAndStockholders Increase (Decrease) in Due to Officers and Stockholders USD 15,454 2009-06-24 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD -4,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap IncreaseDecreaseInNotesPayableCurrent Increase (Decrease) in Notes Payable, Current USD 2,384 2009-06-24 2011-12-31 2012 Q2 10-Q 2012-02-07 0001165527-12-000084
us-gaap IncreaseDecreaseInNotesPayableRelatedPartiesCurrent Increase (Decrease) in Notes Payable, Related Parties, Current USD 10,454 2009-06-24 2012-09-30 2013 Q1 10-Q/A 2012-12-20 0001165527-12-001332
us-gaap IncreaseDecreaseInOperatingCapital Increase (Decrease) in Operating Capital USD 23,684 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-12 0001013762-16-001577
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 1.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 2.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -156,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 2.60M 2020-07-01 2021-03-31 2021 Q3 10-Q 2021-05-13 0001564590-21-027558
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 381,000 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-28 0001564590-21-049235
us-gaap InterestExpense Interest Expense USD 1.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap InterestExpenseDebt Interest Expense, Debt USD 1.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap InterestExpenseDebtExcludingAmortization Interest Expense, Debt, Excluding Amortization USD 205,611 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap InterestExpenseLongTermDebt Interest Expense, Long-term Debt USD 14,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001193125-25-281539
us-gaap InterestIncomeOther Interest Income, Other USD 32,580 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 30,000 2020-07-01 2021-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 233,585 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap InterestPayableCurrent Interest Payable, Current USD 2,091 2014-09-30 2015 Q1 10-Q 2014-11-07 0001013762-14-001293
us-gaap InventoryNet Inventory, Net USD 250,000 2013-12-31 2013 FY 10-K 2014-03-10 0001013762-14-000210
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 33,243 2017-07-01 2018-06-30 8-K 2019-06-03 0001213900-19-009915
us-gaap InvestmentTaxCredit Investment Tax Credit USD 207,080 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-27 0001213900-17-010055
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 185,019 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 40,000 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-28 0001564590-21-049235
us-gaap LegalFees Legal Fees USD 1.55M 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three USD 49,650 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two USD 49,650 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 196,220 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 43,411 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 47,271 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap Liabilities Liabilities USD 17.29M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 36.24M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap LiabilitiesCurrent Liabilities, Current USD 7.76M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap LiabilityForUncertainTaxPositionsNoncurrent Liability for Uncertainty in Income Taxes, Noncurrent USD 0 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap LoansPayable Loans Payable USD 2,384 2011-12-31 2012 Q2 10-Q 2012-02-07 0001165527-12-000084
us-gaap LoansPayableCurrent Loans Payable, Current USD 503,000 2021-03-31 2021 Q3 10-Q 2021-05-13 0001564590-21-027558
us-gaap LoansPayableFairValueDisclosure Loans Payable, Fair Value Disclosure USD 523,000 2021-03-31 2021 Q3 10-Q 2021-05-13 0001564590-21-027558
us-gaap LongTermDebt Long-term Debt USD 9.20M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 33,091 2017-06-30 8-K 2019-06-03 0001213900-19-009915
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 9.20M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 248,690 2017-03-31 2017 Q3 10-Q 2017-05-12 0001213900-17-005082
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 276,439 2014-06-30 2015 FY 10-K 2015-11-16 0001013762-15-001103
us-gaap MarketingExpense Marketing Expense USD 1,500 2010-07-01 2010-09-30 2012 Q1 10-Q 2011-11-10 0001127855-11-000562
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 16.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 8.94M 2017-07-01 2017-12-31 2018 Q2 10-Q 2018-02-14 0001213900-18-001883
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -185,824 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -20,956 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-27 0001213900-17-010055
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -18.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -4.51M 2017-07-01 2017-12-31 2018 Q2 10-Q 2018-02-14 0001213900-18-001883
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -23.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -23.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 48,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap NotesPayableCurrent Notes Payable, Current USD 493,386 2025-09-30 2025 Q3 10-Q 2025-11-14 0001193125-25-281539
us-gaap NotesPayableRelatedPartiesCurrent Notes Payable, Related Parties, Current (Deprecated 2009-01-31) USD 10,454 2012-09-30 2013 Q1 10-Q/A 2012-12-20 0001165527-12-001332
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2023-07-01 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2023-07-01 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap OfficersCompensation Salary and Wage, Officer, Excluding Cost of Good and Service Sold USD 674,055 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-15 0001213900-18-006318
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 56,621 2009-06-24 2012-03-31 2012 Q3 10-Q/A 2012-06-05 0001165527-12-000600
us-gaap OperatingExpenses Operating Expenses USD 21.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -65,008 2009-06-24 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 144,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 221,679 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 134,254 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap OperatingLeasePayments Operating Lease, Payments USD 139,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 270,949 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.1 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap OtherAmortizationOfDeferredCharges Amortization of Other Deferred Charges USD 94,000 2020-07-01 2021-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap OtherAssetsCurrent Other Assets, Current USD 1.79M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 33,754 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap OtherComprehensiveIncomeLossBeforeTax Other Comprehensive Income (Loss), before Tax USD -61,758 2009-06-24 2012-09-30 2013 Q1 10-Q/A 2012-12-20 0001165527-12-001332
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -21,121 2012-01-01 2012-12-31 2014 FY 10-K 2014-08-28 0001013762-14-001054
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 2.67M 2017-07-01 2017-09-30 2018 Q1 10-Q 2017-11-09 0001213900-17-011667
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD -56,708 2009-06-24 2012-03-31 2012 Q3 10-Q/A 2012-06-05 0001165527-12-000600
us-gaap OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent USD 100,868 2015-07-01 2016-06-30 2017 FY 10-K 2017-09-27 0001213900-17-010055
us-gaap OtherExpenses Other Expenses USD 5,623 2009-06-24 2012-03-31 2012 Q3 10-Q/A 2012-06-05 0001165527-12-000600
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 52,000 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 84,985 2025-09-30 2025 Q3 10-Q 2025-11-14 0001193125-25-281539
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 185,019 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -1.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 49,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap OtherReceivables Other Receivables USD 16,011 2015-06-30 2015 FY 10-K 2015-11-16 0001013762-15-001103
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 13,791 2014-09-30 2015 Q1 10-Q 2014-11-07 0001013762-14-001293
us-gaap OtherSellingGeneralAndAdministrativeExpense Other Selling, General and Administrative Expense USD 31,266 2009-06-24 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 24,751 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap PaymentsForSoftware Payments for Software USD 879,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 1.12M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap PaymentsOfDerivativeIssuanceCosts Payments of Derivative Issuance Costs USD 126,186 2018-07-01 2019-06-30 2020 FY 10-K 2020-09-18 0001564590-20-044019
us-gaap PaymentsOfDividendsPreferredStockAndPreferenceStock Payments of Ordinary Dividends, Preferred Stock and Preference Stock USD 6,267 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 25,000 2019-07-01 2020-06-30 2021 FY 10-K 2021-09-28 0001564590-21-049235
us-gaap PaymentsOfMergerRelatedCostsFinancingActivities Payments of Merger Related Costs, Financing Activities USD 500,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 300,000 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap PaymentsToAcquireBusinessTwoNetOfCashAcquired Payments to Acquire Business Two, Net of Cash Acquired USD 1.26M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 16,762 2015-07-01 2016-03-31 2017 Q3 10-Q 2017-05-12 0001213900-17-005082
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 20,000 2023-07-01 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 16.20M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 185,824 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap PaymentsToEmployees Payments to Employees USD 60,000 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap PreferredStockConvertibleConversionRatio PreferredStockConvertibleConversionRatio pure 0.179 2024-03-31 2025 Q3 10-Q 2025-11-14 0001193125-25-281539
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.03 2016-07-01 2017-03-31 2017 Q3 10-Q 2017-05-12 0001213900-17-005082
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 13,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD -676,865 2016-07-01 2017-03-31 2017 Q3 10-Q 2017-05-12 0001213900-17-005082
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 278,530 2017-03-31 2017 Q3 10-Q 2017-05-12 0001213900-17-005082
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 1 2014-06-30 2014 FY 10-K 2014-08-28 0001013762-14-001054
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 278,530 2016-03-31 2016 Q3 10-Q 2016-05-12 0001013762-16-001577
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 258,000 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 2.92M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap PrepaidInsurance Prepaid Insurance USD 20,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ProceedsFromConstructionLoansPayable Proceeds from Construction Loans Payable USD 500,000 2020-07-01 2021-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 2.00M 2023-06-28 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap ProceedsFromGrantors Proceeds from Grantors USD 2.00M 2023-07-01 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 8.00M 2018-07-01 2019-03-31 2019 Q3 10-Q 2019-05-14 0001213900-19-008562
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 8.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 6.54M 2015-07-01 2016-06-30 2017 FY 10-K 2017-09-27 0001213900-17-010055
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 25.00M 2019-07-01 2020-06-30 2020 FY 10-K 2020-09-18 0001564590-20-044019
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 1.49M 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-27 0001213900-17-010055
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 9.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 3.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 10.00M 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-27 0001213900-17-010055
us-gaap ProceedsFromRepaymentsOfOtherLongTermDebt Proceeds from (Repayments of) Other Long-term Debt USD 28.57M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 3,000 2020-07-01 2021-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 8.57M 2013-01-01 2013-12-31 2014 FY 10-K 2014-08-28 0001013762-14-001054
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 104,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 3.62M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 1,162 2009-06-24 2011-09-30 2012 Q1 10-Q 2011-11-10 0001127855-11-000562
us-gaap ProfessionalFees Professional Fees USD 500,000 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -23.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap PropertyPlantAndEquipmentAdditions Property, Plant and Equipment, Additions USD 20,000 2023-07-01 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 2.65M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 407,794 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party CAD 25,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-10 0001013762-14-000210
us-gaap RepaymentsOfAssumedDebt Repayments of Assumed Debt USD 434,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap RepaymentsOfDebt Repayments of Debt USD 500,000 2020-07-01 2021-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 222,450 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 1.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 15.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap RestrictedStockExpense Restricted Stock or Unit Expense USD 3,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -164.36M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap Revenues Revenues USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001193125-26-227245
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 84,984 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 270,949 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 256,940 2016-07-01 2016-09-30 2017 Q1 10-Q 2016-11-10 0001213900-16-018242
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 6.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 53,000 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-28 0001564590-21-049235
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number shares 280,000 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-28 0001564590-21-049235
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 6.14M 2015-06-30 2015 FY 10-K 2015-09-03 0001013762-15-000885
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 60,000 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-12 0001013762-16-001577
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.056 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.012 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.013 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-15 0001013762-14-000563
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.038 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 1.54M 2019-06-30 2019 FY 10-K 2019-09-09 0001213900-19-017497
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 4,000 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 396,538 2016-03-31 2016 Q3 10-Q 2016-05-12 0001013762-16-001577
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 3.01M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 3.85 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value USD/shares 1.57 2021-12-01 2021-12-31 2022 Q2 10-Q 2022-02-11 0001564590-22-004688
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 4.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 4.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.4 2019-07-01 2020-06-30 2020 FY 10-K 2020-09-18 0001564590-20-044019
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 2,000 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 31,000 2023-07-01 2024-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 0.49 2019-07-01 2020-06-30 2020 FY 10-K 2020-09-18 0001564590-20-044019
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 1.02 2022-06-30 2022 FY 10-K 2022-09-27 0000950170-22-018865
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period shares 6,345 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 396,538 2016-03-31 2016 Q3 10-Q 2016-05-12 0001013762-16-001577
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 17.20M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price USD/shares 10 2021-12-01 2021-12-31 2022 Q2 10-Q 2022-02-11 0001564590-22-004688
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 2.1 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 1,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 1.12 2019-07-01 2020-06-30 2020 FY 10-K 2020-09-18 0001564590-20-044019
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 6,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 2.35 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.33 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price USD/shares 1,074.4 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 40 2019-09-30 2020 Q1 10-Q 2019-11-13 0001213900-19-023215
us-gaap SharesHeldInEmployeeStockOptionPlanAllocated Shares Held in Employee Stock Option Plan, Allocated shares 1.02M 2015-06-30 2015 FY 10-K 2015-09-03 0001013762-15-000885
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 5.753 2025-06-30 2025 Q3 10-Q 2025-11-14 0001193125-25-281539
us-gaap ShorttermDebtFairValue Short-term Debt, Fair Value USD 434,000 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108972
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 192,400 2017-07-01 2018-06-30 8-K 2019-06-03 0001213900-19-009915
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 18.95M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 50 2022-11-10 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD 103,000 2023-12-31 2024 Q2 10-Q 2024-02-14 0000950170-24-015204
us-gaap StockholdersEquityPeriodIncreaseDecrease Stockholders' Equity, Period Increase (Decrease) USD 400,957 2014-07-01 2014-12-31 2015 Q2 10-Q 2015-02-12 0001013762-15-000152
us-gaap StockIssued1 Stock Issued USD 15.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 16,000 2022-07-01 2023-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 2.87M 2025-06-30 2025 Q3 10-Q 2025-11-14 0001193125-25-281539
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 43,750 2015-07-01 2016-06-30 2017 FY 10-K 2017-09-27 0001213900-17-010055
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 50 2022-11-10 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 15.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 24.89M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 5.87M 2013-01-01 2013-12-31 2014 FY 10-K 2014-08-28 0001013762-14-001054
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 110,000 2022-07-01 2023-06-30 2024 FY 10-K 2024-10-07 0000950170-24-113321
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 441,521 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 260,969 2016-07-01 2016-09-30 2018 Q3 10-Q 2018-05-15 0001213900-18-006318
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 104,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001193125-26-134950
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 98,000 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-14 0000950170-24-127199
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 24,751 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047921
us-gaap SubscriptionRevenue Subscription and Circulation Revenue (Deprecated 2018-01-31) USD 0 2009-06-24 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap TemporaryEquityForeignCurrencyTranslationAdjustments Temporary Equity, Foreign Currency Translation Adjustments USD -87 2009-06-24 2012-12-31 2013 Q2 10-Q 2013-01-18 0001165527-13-000078
us-gaap TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease) USD 7,355 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-27 0001213900-17-010055
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 433,503 2018-07-01 2019-06-30 2020 FY 10-K 2020-09-18 0001564590-20-044019
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 8.52M 2020-06-30 2020 FY 10-K 2020-09-18 0001564590-20-044019
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 63.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 32.47M 2014-01-01 2014-06-30 2014 FY 10-K 2014-08-28 0001013762-14-001054
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 63.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-459326

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →